117 related articles for article (PubMed ID: 33595948)
1. The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells.
Yamaguchi M; Murata T; Ramos JW
Anticancer Drugs; 2021 Jun; 32(5):558-566. PubMed ID: 33595948
[TBL] [Abstract][Full Text] [Related]
2. The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro.
Yamaguchi M; Murata T; Ramos JW
J Cancer Res Clin Oncol; 2021 Feb; 147(2):339-350. PubMed ID: 33001270
[TBL] [Abstract][Full Text] [Related]
3. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin.
Yamaguchi M; Murata T; Ramos JW
Mol Cell Biochem; 2020 Sep; 472(1-2):173-185. PubMed ID: 32591915
[TBL] [Abstract][Full Text] [Related]
4. An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: Potent effect with polyunsaturated fatty acids.
Yamaguchi M; Hankinson O
Int J Exp Pathol; 2020 Dec; 101(6):248-263. PubMed ID: 32985761
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8‑tetrachlorodibenzo‑p‑dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.
Yamaguchi M; Hankinson O
Int J Oncol; 2019 Apr; 54(4):1422-1432. PubMed ID: 30720065
[TBL] [Abstract][Full Text] [Related]
6. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases.
Yamaguchi M; Murata T; Shoji M; Weitzmann MN
Int J Oncol; 2015 Oct; 47(4):1563-71. PubMed ID: 26238204
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8‑Tetrachlorodibenzo‑p‑dioxin suppresses the growth of human liver cancer HepG2 cells in vitro: Involvement of cell signaling factors.
Yamaguchi M; Hankinson O
Int J Oncol; 2018 Oct; 53(4):1657-1666. PubMed ID: 30066859
[TBL] [Abstract][Full Text] [Related]
8. Impact of CH223191-Induced Mitochondrial Dysfunction on Its Aryl Hydrocarbon Receptor Agonistic and Antagonistic Activities.
Mohammadi-Bardbori A; Omidi M; Arabnezhad MR
Chem Res Toxicol; 2019 Apr; 32(4):691-697. PubMed ID: 30793600
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
Yamaguchi M; Murata T; El-Rayes BF; Shoji M
Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
[TBL] [Abstract][Full Text] [Related]
10. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
11. Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells.
Yamaguchi M; Murata T
Tissue Cell; 2020 Dec; 67():101447. PubMed ID: 33137709
[TBL] [Abstract][Full Text] [Related]
12. Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated HepG2 cells.
de Tomaso Portaz AC; Caimi GR; Sánchez M; Chiappini F; Randi AS; Kleiman de Pisarev DL; Alvarez L
Toxicology; 2015 Oct; 336():36-47. PubMed ID: 26219504
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 Oct; 49(4):1686-94. PubMed ID: 27633001
[TBL] [Abstract][Full Text] [Related]
14. Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.
Choi EY; Lee H; Dingle RW; Kim KB; Swanson HI
Mol Pharmacol; 2012 Jan; 81(1):3-11. PubMed ID: 21967751
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
16. SLC6A19 is a novel putative gene, induced by dioxins via AhR in human hepatoma HepG2 cells.
Tian W; Fu H; Xu T; Xu SL; Guo Z; Tian J; Tao W; Xie HQ; Zhao B
Environ Pollut; 2018 Jun; 237():508-514. PubMed ID: 29522993
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by lipopolysaccharide, PD 98059, dibucaine, or Bay K 8644.
Izumi T; Yamaguchi M
J Cell Biochem; 2004 Oct; 93(3):598-608. PubMed ID: 15378600
[TBL] [Abstract][Full Text] [Related]
18. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
19. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor.
Kim SH; Henry EC; Kim DK; Kim YH; Shin KJ; Han MS; Lee TG; Kang JK; Gasiewicz TA; Ryu SH; Suh PG
Mol Pharmacol; 2006 Jun; 69(6):1871-8. PubMed ID: 16540597
[TBL] [Abstract][Full Text] [Related]
20. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]